Sinonasal disease in cystic fibrosis: Clinical characteristics, diagnosis, and management

Pediatric Pulmonology

Volumn 30, Issue 6, 2000, Pages 481-489

  Gysin, C ^a   Alothman, G A ^a   Papsin, B C ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cystic fibrosis; Endoscopic sinus surgery; Nasal polyposis; Sinus development; Sinusitis; Tobramycin

Indexed keywords

ANTIHISTAMINIC AGENT; DECONGESTIVE AGENT; STEROID; TOBRAMYCIN;

BRONCHITIS; CLINICAL FEATURE; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DRUG EFFICACY; HUMAN; NOSE DISEASE; NOSE MUCOSA; NOSE POLYP; PATHOPHYSIOLOGY; POLYPECTOMY; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CYSTIC FIBROSIS; ENDOSCOPY; HUMANS; INFANT; NASAL MUCOSA; NASAL POLYPS; PARANASAL SINUS DISEASES; PSEUDOMONAS INFECTIONS; QUALITY OF LIFE; RECURRENCE; TOBRAMYCIN;

EID: 0033663989     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-0496(200012)30:6<481::AID-PPUL8>3.0.CO;2-N     Document Type: Review

References (58)

1. Ion transport, ciliary activity and mechanosensitivity of sinusal mucosa: An in vitro study
2. Ciliary function in mucus transport
3. The propulsion of mucus by cilia
4. Measurement of nasal transepithelial electric potential differences in normal human subjects in vivo
5. Nasal mucociliary clearance and ciliary beat frequency in cystic fibrosis compared with sinusitis and bronchiectasis
6. Mucociliary clearance in patients with cystic fibrosis and in normal subjects
7. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease
8. Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro
9. Sinusitis in patients with cystic fibrosis
10. Impact of sinusitis in cystic fibrosis
11. Bacteriology of the maxillary sinuses in patients with cystic fibrosis
12. Cystic fibrosis - An otolaryngologic perspective
13. Treatment and prognosis of nasal polyps in cystic fibrosis
14. Nasal polyps and cystic fibrosis of the pancreas
15. Nasal polyps in cystic fibrosis
16. Differential pathology of nasal polyps in cystic fibrosis and atopy
17. Patterns of sinusitis in cystic fibrosis
18. Abnormal paranasal sinuses in patients with cystic fibrosis of the pancreas
19. The otolaryngologic aspects of cystic fibrosis
20. Management of chronic sinusitis in cystis fibrosis
21. Coronal CT scan abnormalities in children with chronic sinusitis
22. Pathological changes of the lateral nasal wall in patients with cystic fibrosis (mucoviscidosis)
23. Nasal polypectomy and sinus surgery for cystic fibrosis - A 10 year review
24. Paranasal sinus mucocele in cystic fibrosis
25. Paranasal sinus disease in patients with cystic fibrosis
26. Bilateral maxillary sinus mucoceles in an infant with cystic fibrosis
27. Recognition of a paranasal sinus mucocele in a child with cystic fibrosis
28. Upper respiratory disease, sinusitis, and polyposis
29. Symptom outcome after functional endoscopic sinus surgery in patients with cystic fibrosis: A prospective study
30. The results of functional endoscopic sinus (FES) surgery on the symptoms of patients with cystic fibrosis
31. Management of sinusitis in children
32. Mucociliary clearance and buffered hypertonic saline solution
33. Physiologic and hypertonic saline solutions impair ciliary activity in vitro
34. Pneumolysin produced by Streptococcus pneumoniae damages human respiratory epithelium in vitro
35. The effect of long-term antibiotic therapy upon ciliary beat frequency in chronic rhinosinusitis
36. Extrapulmonary sites of Pseudomonas aeruginosa in adults with cystic fibrosis
37. Long-term effect of inhaled tobramycin in patients with cystic fibrosis colonised with Pseudomonas aeruginosa
38. Efficacy of aerosolized tobramycin in patients with cystic fibrosis
39. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis
40. Assessment of potential ototoxicity following high-dose nebulized tobramycin in patients with cystic fibrosis
41. Cystic fibrosis patients who have undergone heart-lung transplantation benefit from maxillary sinus antrostomy and repeated sinus lavage
42. Infections in patients with cystic fibrosis following lung transplantation
43. Allograft colonization and infections with Pseudomonas in cystic fibrosis lung transplant recipients
44. Bilateral lung transplantation for cystic fibrosis
45. Management of sinusistis in cystic fibrosis by endoscopic surgery and serial antimicrobial lavage
46. Endoscopic nasal surgery - Concepts in treatment of recurring rhinosinusitis. Part II. Surgical technique
47. Pediatric sinusitis
48. Functional endoscopic surgery in children: A retrospective analysis of results
49. Initial report on postoperative healing after endoscopic sinus surgery with the microdebrider
50. The hummer, shaver or microdebrider
51. How I do it: Nasal polypectomy with an arthroscopic bone shaver the Stryker hummer
52. Nasal and sinus polyposis in children
53. Nasal and paranasal sinus surgery in children with cystic fibrosis
54. Functional endoscopic sinus surgery in patients with chronic sinusitis and asthma
55. Sinus disease in patients with severe cystic fibrosis: Relation to pulmonary exacerbation
56. Effect of sinus surgery on pulmonary function in patients with cystic fibrosis
57. Sequential magnetic resonance imaging analysis of the maxillary sinuses: Implications for a model of gene therapy in cystic fibrosis